Antiviral compound provides full protection from Ebola virus in nonhuman primates

9 octubre 2015

Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus’s ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to new research findings.